HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Relic Selected Research

Bufexamac (Jomax)

2/2019Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Relic Research Topics

Disease

1Allergic Contact Dermatitis
02/2019
1Congenital Abnormalities (Deformity)
05/2017
1Inflammation (Inflammations)
11/2015
1Phobic Disorders (Phobia)
11/2015
1Atopic Dermatitis (Atopic Eczema)
11/2015
1Eczema
11/2015
1Granuloma
02/2010
1Epidermolysis Bullosa
01/2008

Drug/Important Bio-Agent (IBA)

1Bufexamac (Jomax)IBA
02/2019
1Propranolol (Inderal)FDA LinkGeneric
05/2017
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2015
1AcidsIBA
02/2010
1Methenamine (Hexamine)IBA
02/2010
1Integrin alpha6beta4IBA
01/2008

Therapy/Procedure

1Therapeutics
11/2015